Valuations of Early-Stage Companies and Disruptive Technologies How to Value Life Science, Cybersecurity and ICT Start-ups, and their Technologies /
| 第一著者: | |
|---|---|
| 団体著者: | |
| 要約: | XII, 219 p. 11 illus., 5 illus. in color. text |
| 言語: | 英語 |
| 出版事項: |
Cham :
Springer International Publishing : Imprint: Palgrave Macmillan,
2020.
|
| 版: | 1st ed. 2020. |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1007/978-3-030-38847-8 |
| フォーマット: | 電子媒体 eBook |
目次:
- Part I. A Short Overview of Valuations
- Chapter 1. Introduction
- Chapter 2. Understanding Financial Valuations and Basic Traditional Techniques
- Part II. Overcoming Valuation Hurdles: How to Conduct Valuations Under Unique Circumstances
- Chapter 3. Understanding the Basic Elements of Stockholder Statements and their Use in Valuations
- Chapter 4. Valuation Methods: The First Chicago Venture Method and the Use of Real Options
- Part III. Behavioral Factors: How Psychology Affects Bias in Valuations
- Chapter 5. Introduction to Behavioral Finance
- Chapter 6. An Overview of Investor Behavior in Financial Markets and Psychological Influences on Valuations
- Chapter 7. How to Overcome Investor Behavior and Psychological Influences in Valuations: How to Evaluate a Dream?
- Part IV. An Introduction to Valuations in R&D-Intensive Industries
- Chapter 8. The Pharmaceutical Sector
- Chapter 9. Life Sciences: Disrupting Biologic Drugs Manufacturing
- Chapter 10. An Overview of the Cybersecurity and the Renewable Energy Sectors
- Part V. Actual Valuations
- Chapter 11. Company A: Pharmaceutical / New Compounds
- Chapter 12. Company B: Pharmaceutical / Biologies
- Chapter 13. Company C: Cybersecurity
- Chapter 14. Company D: Renewable Energy
- Chapter 15. Conclusion.